Corbus Pharmaceuticals Holdings (CRBP) Operating Income Growth (3y) (2016 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Operating Income Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,071.81 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,925.70 Bn | 1,925.64 Bn | - | - |
| 3 | Akari Therapeutics | 1,062.88 Bn | 1,062.88 Bn | - | - |
| 4 | BeOne Medicines | 469.09 Bn | 464.29 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 123.09 Bn | 115.84 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 70.32 Bn | 61.57 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 63.36 Bn | 63.36 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.71 Bn | 1.41 Bn | 69.02% |
| 9 | Alnylam Pharmaceuticals | 37.69 Bn | 34.68 Bn | 959.66 Mn | 55.96% |
| 10 | Corbus Pharmaceuticals Holdings | 116.37 Mn | 88.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -43.98% |
| Jun 30, 2025 | 28.19% |
| Mar 31, 2025 | 30.01% |
| Dec 31, 2024 | 29.62% |
| Sep 30, 2024 | -3.77% |
| Jun 30, 2024 | 13.03% |
| Mar 31, 2024 | 27.38% |
| Dec 31, 2023 | 21.41% |
| Sep 30, 2023 | 34.64% |
| Jun 30, 2023 | 40.12% |
| Mar 31, 2023 | 16.66% |
| Dec 31, 2022 | 26.50% |
| Sep 30, 2022 | 31.18% |
| Jun 30, 2022 | -109.82% |
| Mar 31, 2022 | 31.52% |
| Dec 31, 2021 | 17.17% |
| Sep 30, 2021 | 2.34% |
| Jun 30, 2021 | -10.45% |
| Mar 31, 2021 | -9.12% |
| Dec 31, 2020 | -24.20% |